31.52
price up icon2.94%   0.90
pre-market  Vorhandelsmarkt:  31.99   0.47   +1.49%
loading

Finanzdaten der Veracyte Inc-Aktie (VCYT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-03-31 2023-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
13.71%
130.16
114.47 115.86 96.84 98.20
Cost Of Revenue
15.53%
40.40
34.97 36.85 - -
Gross Profit
12.91%
89.77
79.51 79.01 - -
Operating Expenses
24.06%
95.04
76.60 66.99 101.50 133.71
Benefits Costs and Expenses
20.43%
128.91
107.05 99.01 98.75 128.67
Costs And Expenses
24.06%
95.04
76.60 66.99 101.50 133.71
Operating Income/Loss
281.40%
-5.268
2.904 12.02 -4.656 -35.51
Income/Loss From Continuing Operations Before Tax
83.17%
1.25
7.428 16.85 -1.908 -30.47
Income Tax Expense/Benefit
485.30%
2.23
0.381 1.693 -0.044 -2.179
Income/Loss From Continuing Operations After Tax
113.91%
-0.98
7.047 15.15 -1.864 -28.29
Net Income/Loss
113.91%
-0.98
7.047 15.15 -1.864 -28.29
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.47%
78.39
78.03 77.01 74.76 0.1559
Diluted Average Shares
2.08%
78.39
80.06 78.46 74.76 0.1559
Basic Earnings Per Share
111.11%
-0.01
0.09 0.20 -0.02 -0.38
Diluted Earnings Per Share
111.11%
-0.01
0.09 0.19 -0.02 -0.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research WAT
$299.69
price up icon 3.32%
diagnostics_research DGX
$180.11
price up icon 0.33%
$166.56
price down icon 0.58%
diagnostics_research LH
$275.23
price up icon 0.51%
diagnostics_research MTD
$1,287.79
price up icon 1.51%
diagnostics_research IQV
$184.08
price down icon 0.29%
Kapitalisierung:     |  Volumen (24h):